Fourway Pharma LLP

Infanrix hexa is a six-in-one vaccine used for the primary and booster vaccination of infants and young children against six serious diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis (polio), and invasive diseases caused by Haemophilus influenzae type b (Hib). It works by stimulating the immune system to produce antibodies to protect against these infections, which can otherwise cause severe health issues like paralysis, respiratory problems, and organ damage. 

Hexasiil is a hexavalent vaccine used to actively immunize infants aged six weeks and older against six serious diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis (polio), and invasive diseases caused by Haemophilus influenzae type b (Hib). A primary vaccination series consists of three doses given at 6, 10, and 14 weeks, followed by a booster dose between 12 and 24 months of age. 

Easy Six is a combination vaccine that protects infants and toddlers against six diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis (polio), and severe infections from Haemophilus influenzae type b*. It is given as a primary series of doses at around 6, 10, and 14 weeks of age, with a booster dose in the second year of life, to help build immunity to these serious illnesses. 

Varilrix is a vaccine used to prevent chickenpox (varicella) in healthy individuals, including children from 9 months of age and adults. It may also be used for post-exposure prophylaxis if given within 72 hours of contact with the virus. The vaccine works by stimulating the immune system to produce antibodies against the varicella-zoster virus, and it is typically administered as two doses.

Anti-D 300mcg injection prevents Rh disease (hemolytic disease of the newborn) by stopping an Rh-negative person's immune system from attacking Rh-positive blood cells, crucial during pregnancy for Rh-negative mothers with Rh-positive babies, after miscarriages, or following mismatched Rh-positive blood transfusions in Rh-negative patients, protecting future pregnancies and health. 

• Pregnancy: Given to Rh-negative mothers during the third trimester and after delivery (if the baby is Rh-positive) to prevent sensitization. 
• Miscarriage/Abortion: Administered after a miscarriage or abortion to Rh-negative women to stop immune response to fetal blood. 
• Trauma/Procedures: Given after abdominal trauma, amniocentesis, or other events where fetal blood might enter the mother's system. 
• Blood Transfusions: Used for Rh-negative individuals who accidentally receive Rh-positive blood.